The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.95
Bid: 2.90
Ask: 3.00
Change: -0.17 (-5.57%)
Spread: 0.10 (3.448%)
Open: 3.05
High: 2.88
Low: 2.88
Prev. Close: 3.05
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: ValiRx receives shareholder request for board change

Fri, 09th Feb 2024 20:24

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says it has received a requisition notice from a shareholder group proposing certain changes to the board. Seeks legal advice as to the validity of the requisition notice and a further announcement will be made in due course.

----------

The Property Franchise Group PLC - Bournemouth, England-based lettings and estate agency franchising firm - Reports close to 100% shareholder backing for the all-share merger with The Belvoir Group PLC at the General Meeting.

----------

Kin and Carta PLC - London-based business software consultancy - Ahead of the Court Meeting and General Meeting, reiterates unanimous recommendation that scheme shareholders vote in favour of the scheme at the Court Meeting and the special resolution proposed at the General Meeting. This is to facilitate the bid for Kin and Carta by Valtech. Points out that Apax Partners, which had also made a bid for the company, said Friday it would not increasing the terms of its 120 pence per share offer. Valtech's bid is worth 130p per Kin and Carta share. Explains discussions with other parties had not led to a bid for the company, and no talks are currently ongoing.

----------

Catenae Innovation PLC - London-based digital media and technology provider using blockchain technology to support clients with operations and staff management - Says at Annual General Meeting all resolutions were passed including name change to Catenai PLC and the share capital reorganisation. Once the change of name takes effect, the group's ticker for AIM will be CTAI.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
14 Jul 2016 08:50

ValiRx Receives Approval To Submit Application For Cancer Drug Trial

Read more
7 Jul 2016 07:50

ValiRx Sells TRAC Technology To Germany's Sovicell For EUR800,000

Read more
13 Jun 2016 15:02

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jun 2016 09:19

ValiRx Highlights Progress With VAL201 Lead Compound, VAL401 Venture

Read more
19 May 2016 15:44

ValiRx updates market on 'significant' 2015

(ShareCast News) - Lifesciences company ValiRx reported on a "significant year" on Thursday, talking up its capital restructure and technical advancements in the 2015 calendar year. The AIM-traded firm, which focuses on cancer therapeutics and diagnostics for personalised medicine, said its Phase I/

Read more
19 May 2016 10:29

ValiRx Loss Narrows As Progress Is Made On Cancer Compounds

Read more
19 May 2016 09:23

ValiRx Says ValiSeek Begins Manufacturing VAL401 For Clinical Trial

Read more
29 Apr 2016 07:50

ValiRx Says ValiSeek Gets US Patent For VAL401 In Adenocarcinoma

Read more
19 Apr 2016 14:45

ValiRx Shares Fall After Bracknor Converts GBP200,000 Of Loan Notes (ALLISS)

Read more
1 Apr 2016 14:28

ValiRx Receives Conversion Notice For GBP90,000 From Bracknor (ALLISS)

Read more
21 Mar 2016 08:29

ValiRx Strikes GBP4 Million Convertible Funding Deal With Bracknor (ALLISS)

Read more
17 Mar 2016 09:07

ValiRx Hires Consultancy Firm Burns McClellan To Boost US Profile

Read more
17 Feb 2016 13:04

ValiRx Raises Funds To Back Ongoing Drug Trials (ALLISS)

Read more
16 Feb 2016 13:17

ValiRx achieves success in latest VAL201 trial

(ShareCast News) - ValiRx was pressing ahead with the trial process for its VAL201 trial treatment on Tuesday, following positive results from the most recent tranche of test patients. The AIM-traded life science company, with a focus on cancer diagnostics and therapeutics for personalised medicine,

Read more
16 Feb 2016 09:16

ValiRx Says Final Dose Escalation For VAL201 Trials Approved

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.